Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 9/20 | 0.47 |
| ▸ | NPY4R | P50391 | 7/20 | 0.42 |
| ▸ | NPY1R | P25929 | 5/20 | 0.42 |
| ▸ | NPY2R | P49146 | 4/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28776590 | 1.00 | ENPEP (0.47) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL3780313 | 1.00 | ENPEP (0.47) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30968271 | 0.97 | ENPEP (0.46) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31074246 | 0.96 | ENPEP (0.49) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30686008 | 0.94 | ENPEP (0.43) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31174192 | 0.94 | NPY4R (0.50) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31174188 | 0.94 | NPY4R (0.50) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30686006 | 0.94 | ENPEP (0.43) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30631320 | 0.93 | NPY4R (0.41) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL22089839 | 0.91 | NPY4R (0.50) | ENPEPNPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12449424-B2 | In vitro method for detecting avian intestinal dysbiosis | EVONIK OPERATIONS GMBH (DE) | 2025-10-21 | — | — | US | disclosed |
| US-12389931-B2 | Oyster peptide with effect of improving sexual function and preparation method thereof | CHINA NATIONAL RESEARCH INSTITUTE OF FOOD & FERMENTATION INDUSTRIES CO., LTD. (CN) | 2025-08-19 | — | — | US | disclosed |
| EP-3894863-B1 | IN VITRO METHOD FOR DETECTING AVIAN INTESTINAL DYSBIOSIS | EVONIK OPERATIONS GMBH (DE) | 2022-11-23 | — | — | EP | disclosed |
| US-20220248737-A1 | OYSTER PEPTIDE WITH EFFECT OF IMPROVING SEXUAL FUNCTION AND PREPARATION METHOD THEREOF | CHINA NATIONAL RESEARCH INSTITUTE OF FOOD & FERMENTATION INDUSTRIES CO., LTD. (CN) | 2022-08-11 | — | — | US | disclosed |
| US-20220050115-A1 | IN VITRO METHOD FOR DETECTING AVIAN INTESTINAL DYSBIOSIS | EVONIK OPERATIONS GMBH (DE) | 2022-02-17 | — | — | US | disclosed |
| US-20220050115-A1 | IN VITRO METHOD FOR DETECTING AVIAN INTESTINAL DYSBIOSIS | EVONIK OPERATIONS GMBH (DE) | 2022-02-17 | — | — | US | disclosed |
| EP-3894863-A1 | IN VITRO METHOD FOR DETECTING AVIAN INTESTINAL DYSBIOSIS | Evonik Operations GmbH (DE) | 2021-10-20 | — | — | EP | disclosed |
| CN-113167803-A | In-vitro detection method for poultry intestinal dysbiosis | 赢创运营有限公司 | 2021-07-23 | — | — | CN | disclosed |
| EP-3546940-B1 | BIOMARKERS RELATED TO KIDNEY FUNCTION AND METHODS USING THE SAME | METABOLON INC (US) | 2021-02-17 | — | — | EP | disclosed |
| WO-2020120376-A1 | IN VITRO METHOD FOR DETECTING AVIAN INTESTINAL DYSBIOSIS | EVONIK OPERATIONS GMBH (DE) | 2020-06-18 | — | — | WO | disclosed |
| US-5728566-A | Tissue plasminogen activator derivatives | GENENTECH, INC. (US) | 1998-03-17 | — | — | US | disclosed |
| US-5728565-A | Methods of preparing tissue plasminogen activator derivatives | GENENTECH, INC. (US) | 1998-03-17 | — | — | US | disclosed |
| US-5702938-A | Human tissue plasminogen activator | GENETECH, INC. (US) | 1997-12-30 | — | — | US | disclosed |
| US-5587159-A | POLYPEPTIDES | GENENTECH, INC. (US) | 1996-12-24 | — | — | US | disclosed |
| EP-0093619-B2 | Human tissue plasminogen activator, pharmaceutical compositions containing it, processes for making it, and DNA and transformed cell intermediates therefor | GENENTECH INC (US) | 1996-09-18 | — | — | EP | disclosed |
| US-5185259-A | Recombinant human tissue plasminogen activator of high purity | GENENTECH, INC. (US) | 1993-02-09 | — | — | US | disclosed |
| EP-0093619-B1 | HUMAN TISSUE PLASMINOGEN ACTIVATOR, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, PROCESSES FOR MAKING IT, AND DNA AND TRANSFORMED CELL INTERMEDIATES THEREFOR | GENENTECH, INC. (US) | 1989-09-13 | — | — | EP | disclosed |
| US-4853330-A | Human tissue plasminogen activator | GENENTECH, INC. (US) | 1989-08-01 | — | — | US | disclosed |
| US-4766075-A | FROM CELL CULTURES USING RECOMBITANT DNA | GENENTECH, INC. (US) | 1988-08-23 | — | — | US | disclosed |
| EP-0093619-A1 | Human tissue plasminogen activator, pharmaceutical compositions containing it, processes for making it, and DNA and transformed cell intermediates therefor | GENENTECH, INC. (US) | 1983-11-09 | — | — | EP | disclosed |